Cell Therapy Catapult appoints Eversheds as legal adviser

Eversheds has been appointed as legal adviser to the Cell Therapy Catapult, a UK centre of excellence in cell therapy, following a competitive pitch process.

The law firm’s appointment will cover all aspects of the Cell Therapy Catapult’s operations, including intellectual property and life sciences issues, procurement and state aid, HR, real estate and construction.

The Cell Therapy Catapult was established by the UK government’s Technology Strategy Board in 2012 to grow the UK cell therapy industry by removing the barriers to translation of promising therapies and technologies into new products.

  • Print

Briefings from Eversheds

  • Market abuse regime

    The current EU market abuse regime is in line for an overhaul. It is anticipated that the implementation of the new proposals may not come into force until 2016.

  • Unfair relationships — what does the future hold?

    The ‘unfair relationship’ concept in respect of credit agreements was introduced into the Consumer Credit Act 1974 on 6 April 2007.

View more briefings from Eversheds

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

1 Wood Street
London
EC2V 7WS
UK
http://www.eversheds.com

Turnover (£m): 376.00
No. of Lawyers: 1,264
No. of Lawyers (Asia Pacific): 68
Offices (Asia Pacific): 3

Jobs

View all jobs from this firm